Lightspeed is in discussions to lead the funding round, sources say.

Lightspeed is in discussions to lead the funding round, sources say.

Miles Wang, an OpenAI researcher, is in talks to raise $200M at a $2bn valuation for an AI drug-discovery startup that has no name or product yet.